Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section.
Fricker
R M
RM
Department of Anesthesiology and Intensive Care Medicine (B), General Hospital, University of Vienna, Austria. ruth.fricker@univie.ac.at
Hoerauf
K H
KH
Drewe
J
J
Kress
H G
HG
D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects*; D003620:Dantrolene / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007774:Lactation; D008305:Malignant Hyperthermia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D008895:Milk, Human; D009125:Muscle Relaxants, Central / Q000009:adverse effects* / Q000627:therapeutic use*; D011247:Pregnancy
D009125:Muscle Relaxants, Central; D003620:Dantrolene